Borderline contingent and mislabeled debt

Selected findings from library records with scoped primary-source review.

Research reference · Consumer guides and topic map

Plain-English guides on this topic

One merger contingent value right

Library record saved 2026-11-11

Research scope and limits

Actual milestones, entitlement, enforceability, tax and broader classification remain open.

  • The filed February 3, 2026 Cycle Group and Equiniti agreement creates conditional merger consideration for covered holders and generally restricts transfer except Permitted CVR Transfers.

    d216453dex99d5.htm · www.sec.gov

  • Second milestone requires defined FDA approval for CMT-SORD by the specified deadline and before termination. The one-time per-CVR cash amount is $0.10 without interest; holder count is the register at notice-date close of business. Parent notice/certification and funding follow the earlier of 90 days and next March 15.

    d216453dex99d5.htm · www.sec.gov

  • The contract selects Delaware law; actual classification and enforcement under that law remain held.

    d216453dex99d5.htm · www.sec.gov

Applied Therapeutics CVR public document chain

Library record saved 2026-11-11

Research scope and limits

Actual milestone, amendment, termination, successor and tax remain held.